Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast Cancer : a Randomized Controlled, Pilot Study

NCT06158347 is registered in ClinicalTrials.gov with Ilsan Cha hospital as lead sponsor.

NCT NCT06158347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06158347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast Cancer : a Randomized Controlled, Pilot Study
Lead sponsor
Ilsan Cha hospital
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2023
Completion date
September 25, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, radiation dermatitis